EVENTS AND PREMIER CONFERENCES

Professional development and networking
opportunities for the life sciences community

MassBio hosts must-attend events for members through our professional development forums and mixers, and the industry at large through our premier conferences. We also offer members exclusive access to our conference and business center, the MassBioHub, to host their own events.


Premier Conferences

Our premier conferences bring together top industry leaders and key stakeholders to discuss relevant topics in all major segments of the life sciences sector. Premier conferences include:

Digital Health Impact

The convergence between digital health and the life sciences is creating new opportunities to transform patient care as well as drug discovery and development. From wearables to machine learning, digital technologies are easing data collection from patients, increasing medical adherence, supplementing clinical trials, and offering new insights into real-world applications of therapies. Embedding digital health tools into the life sciences will also allow new therapies to better work within the growing value-based healthcare system that relies on data and measurable outcomes.

MassBio’s annual Digital Health Impact 2020 event examines the current state of digital health as it relates to the life sciences, the challenges facing its growth, and opportunities for collaboration. Through keynotes, panel discussions, and case studies, we’ll explore new strategies for therapeutics and digital health innovators to converge and ultimately deliver better outcomes for patients.

To inquire about sponsorship opportunities, contact Laura Rudberg.

Patient Advocacy Summit

MassBio’s Patient Advocacy Summit brings together the patient advocacy community to showcase best practices and cutting-edge examples of how life sciences companies can more fully incorporate the patient voice into the work they do—not just approaching regulatory applications or at commercialization, but throughout the drug development cycle.

The program includes panel discussions, case study presentations (spotlighting industry/patient partnerships), an inspirational keynote address, as well as a networking breakfast, lunch, and cocktail reception.

To inquire about sponsorship opportunities, contact Laura Rudberg.

Policy Leadership Breakfast

With policies impacting our industry at the forefront of state legislators’ minds, MassBio’s annual Policy Leadership Breakfast will debate the most pressing policy initiatives facing the life sciences industry. This event is a must-attend for senior industry leaders, policymakers and life sciences government affairs executives.

The event includes keynotes presentations and panel discussions designed to educate and promote an open dialogue. Speakers will address the necessary shift in mindset from measuring costs to measuring value, whether that’s exploring new models for more efficient R&D, piloting innovative pricing models, or working directly with patients to define desired outcomes and endpoints.

To express interest in sponsoring or exhibiting at this event, contact Susan Martin.

Rare Disease Day

Every year, MassBio celebrates Rare Disease Day by bringing together nearly 300 industry stakeholders to elevate public understanding of rare diseases and call attention to the special challenges people with these ailments face.

The event convenes patient organizations, government agencies, medical researchers, life sciences companies and patients to share stories and recognize the great work being done in Massachusetts and beyond to provide new treatments and cures for diseases that affect nearly 30 million Americans.

To inquire about sponsorship opportunities, contact Laura Rudberg.

State of Possible Conference (MassBio’s Annual Meeting)

MassBio’s State of Possible Conference celebrates what’s possible in our industry and for patients today that wasn’t five or 10 years ago. The two-day event draws over 600 industry leaders from Massachusetts and beyond to debate the most pressing challenges facing the life sciences to ensure we can continue this incredible success. Attendees hear from the brightest minds through keynotes, panel discussions and 15-minute Possible Talks, inspiring and engaging content in the style of a TED Talk.

“It’s the Woodstock of Life Sciences, with all star performers playing their greatest hits all on one stage.” – 2019 State of Possible Conference attendee

To inquire about sponsorship opportunities, contact Laura Rudberg.

Learn more about event sponsorship here.

Networking Mixers

Regular networking mixers across the state provide members, from young professionals to executives, an opportunity to engage with our members from the broader life sciences community. Mixers include:

  • St Patrick’s Day Mixer
  • Red Sox Networking Event
  • Oktoberfest
  • Brewery Series
  • Holiday Party
  • Executive Series
  • Regional Mixers (various locations across the state)

Learn more about event sponsorship here.

Professional Development Forums

Our professional development forums are offered exclusively for members to debate industry hot topics, tackle common challenges, share best practices, and network. Forums are free of charge and are planned by our Forum Working Groups, comprised of volunteers from member organizations who help develop timely programming on a wide variety of industry topics. Forum Working Groups include:

Academic Industry Relations  

Mission: Fostering a shared understanding and greater, more effective collaboration between academia and industry to improve healthcare innovation for patients.

Leadership – Co-Chairs:

  • Irena Ivanovska, Ph.D., Director, Celdara Medical (ADD)
  • Lucie Rochard, Liaison for Scientific & Entrepreneurial initiatives, Innovation Services, MassBio
  • Andrea Schievella, Ph.D., President and Head of Business Development, Cancer Research Technology, Inc.
  • Tracy Schmidt, Ph.D., Associate Director, Corporate and Foundation Relations, Tufts University
  • Alexander Lin, Director, Center for Clinical Spectroscopy; Assistant Professor of Radiology, Brigham and Women’s Hospital, Harvard Medical School
Clinical Development, Biostatistics & Data Management (BSDMCT)

Mission: To provide a Forum for presenting and reviewing new ideas and findings in clinical research and drug discovery and to ensure consistency in clinical trials and efficacy in lead development. Discussions will feature industry and regulatory guidelines, journals, articles, references, standard operating procedures and consultant resources for conducting clinical trials, both with in house expertise or external clinical trial organizations. 

Leadership – Co-Chairs:

  • Kevin Anderson, MBA, Director, Global Clinical Operations, Alexion Pharmaceuticals
  • Michelle Harrison, Associate Director, Clinical Data Management, Vertex Pharmaceuticals 
  • Miganush Stepanians, PhD, President & CEO, PROMETRIKA, LLC
  • Ilker Yalcin, PhD, VP, Biostatistics, Tesaro, Inc.
Business Development and Finance (BD/Fin)

Mission: To provide a Forum to address the challenges of driving innovation to commercialization in the rapidly evolving Biotech and Pharma industries and acquiring a competitive advantage via engaging academia and accessing innovation from external sources.  Discussions will focus on various business models including licensing, merger and acquisition and the venture capital community

Leadership – Co-Chairs:

  • Paul Conrad, PhD, MBA, Vice President, Business Development, bluebird bio
  • Wanni Davis, PhD, MBA, Senior Director, Alliance Management and Business Development, Cue Biopharma 
  • Jacqueline Liu, CPA, MBA, Sr. Director, Finance, Forma Therapeutics, Inc.
  • Arindrajit Basak, Founder & CEO, Catailyst Inc.
​​Drug Discovery (DD)

Mission: To provide a Forum for drug discovery and early development executives, managers and researches to exchange ideas, information and resources in order to expedite the discovery and validation of new targets and drugs. Forums will focus on small molecule, biological and platform technologies, as well as, academic research.

Leadership – Co-Chairs:

  • Andy Snyder, PhD, Principal Scientist & Head of Cell Biology, Twentyeight-Seven Therapeutics
  • Qi-Ying Hu, PhD, Director of Drug Delivery, Decibel Therapeutics
  • Jane Withka, Director and Collaboration Lead in Medicine Design, Pfizer
Drug Formulation Development, Manufacturing & Supply  

Mission: To provide a Forum for open discussions on rapidly evolving scientific and technology topics on drug formulation, CMC, manufacturing and supply chain management to help move the industry forward in getting traditional to advanced therapies produced cost effectively and with the highest quality and delivered to the individual patients who need them.  

Leadership – Co-Chairs:

  • Gerry Cox, Co-Founder & COO, Velesco Pharmaceutical Services
  • Parika Petaipimol, Associate Director, Program Management, Pandion Therapeutics
  • Liza Rivera, Global Marketing Director at FUJIFILM Diosynth Biotechnologies
  • Kevin Slatkavitz, President/Founder ThinkQuality, LLC
  • Bayan Takizawa, MD, Co-Founder & Chief Business Officer, CONTINUUS Pharmaceuticals 
  • Xiang Yang Yu, PhD, Program Manager, Accellient Partners
Entrepreneur’s University (EU)

Mission: To provide a forum for business leaders to present key elements essential for guiding startups from creative ideas and R&D through the development of business opportunities that fuel company operations and growth. Discussions will include hot topics for entrepreneurs such as strategic investments and alliances, board development and management, term sheets, and negotiation strategies. 

Leadership – Co-Chairs:

  • Steve Altieri, PhD, JD, Associate, Morgan, Lewis & Bockius LLP
  • Marc Cote, Biotech Entrepreneur & Certified Business Coach, FocalPoint Business Coaching
  • John Hession, Partner, Morse, Barnes-Brown & Pendleton, PC
Human Resources (HR)

Mission: To provide educational and informative programming for professionals of all levels on a broad spectrum of HR topics. Discussions will bring additional expertise and insight to the complex human resource issues impacting the Biotech industry and the HR community. 

Leadership – Co-Chairs:

  • Lauren Celano, MBA, Co-founder & CEO, Propel Careers
  • Chris Tamburrini, Managing Director, AP Biosciences & Healthcare, AP Staffing
  • Cheryl Vaughan, Managing Director, Learning and Development Programs, Boston Biomedical Innovation Center
  • Anna Welland, Associate Director, Human Resources, Platelet BioGenesis
Legal

Mission: To foster cooperation and mutual assistance amongst attorneys practicing in the areas of IP, biotech, healthcare and employment law.  

Leadership – Co-Chairs:

  • Lana Gladstein, Vice President and General Counsel, Brammer Bio
  • John Harre, Founder, L.G.L Consulting
  • Dan Shores, Partner, Rothwell Figg
Regulatory

Mission: Provide a forum to help ensure that new products and therapies meet or exceed regulatory standards and that life sciences professionals establish and maintain good working relationships with regulatory authorities.

Leadership – Co-Chairs:

  • Mark Ammann, PharmD, Senior VP, Regulatory Affairs, Veristat, LLC
  • Bae Lo, Director, Global Regulatory Affairs, Rare Disease, Sanofi Genzyme
  • Michelle Wells, Vice President Regulatory Affairs, Frequency Therapeutics
  • Andrew S. Verderame, Partner, Regulatory and Development Consulting, PharmaLex US
Marketing, Communications & Commercialization (MarComm)

Mission: To provide a Forum for professionals to discuss and collaborate on best practice marketing and communications issues affecting biotechnology companies – small, medium and large. Discussions will include investor relations, public relations/affairs, marketing issues (discovery through commercialization) and corporate strategies impacting the evolution of biotech and pharma companies.

Leadership – Co-Chairs:

  • Eric Laub, Reputation & Risk Management, Syneos Health
  • Nick Lowe, Founding Partner, Zozimus
  • Rebecca Peterson, Principal, Peterson Communications, LLC
  • Marie Sanchirico, Director – Field Medical, National Accounts, Intercept Pharmaceuticals (UPDATE)
  • Jeroen van der Lans, Head of Operations & Services, Commercial, Takeda
  • Elsa Navarro, Senior Advisor, Market Access Practice, Evidera
Medical Device, Diagnostics & Digital Health (MedDev, AI, ML)

Mission: To provide a forum addressing the trends, regulatory challenges, innovation, and rapid growth and development of medical devices. We will strive to represent the diverse aspects of this sector including diagnostics, imaging, drug delivery, implantables, biosensing, combination products, therapeutics, and more. Forums will present hot topics, high-value expertise and provide opportunities for the exchange of ideas and open discussion of development, commercialization, case studies, clinical trials, and promote the success and awareness of the medical device community contributions to the Massachusetts life sciences supercluster. 

Leadership – Co-Chairs:

  • Anu Gaur, Adjunct Faculty, Northeastern University and Founder & President, Synergy Global Regulatory Affairs Consultancy
  • Jeremy Bond, MSc, JD, Senior Counsel, Device Patents, Sanofi
  • Charmaine Demanuele, Director, Early Clinical Development Biostatistics, Pfizer
  • Roman Fayerberg, ME, JD, Shareholder & Patent Attorney, Greenberg Traurig LLP
  • Barry Sands, MBA, President & Founder, RQMIS, Inc.
  • Evan Sherr, MS, VP Operations, Windgap Medical, Inc.
Nonprofit (NP)

Mission: To provide a Forum where Massachusetts nonprofit organizations in the life science industry can intersect with each other and with for-profit companies for mutual benefit and to share best practices. Discussions will address all aspects of healthcare non-profit operations including academia/industry collaboration, novel business models, non-profit operations and workforce development. In addition, Forum meetings will provide an education in and opportunities for philanthropy enabling those vested in both corporate social responsibility and innovation to discover non-profit organizations for collaboration.

Leadership Co-Chairs:

  • Joanne Kamens, PhD, Executive Director, Addgene
  • Ann Sluder, PhD, Associate Director, Sr. Research Project Manager, Vaccine & Immunotherapy Center, Massachusetts, General Hospital
  • Lori Ryan, RN, MS, Chair Board of Directors, Neurofibromatosis Northeast
  • Milka Kostic, PhD, Program Director, Chemical Biology, Dana-Farber Cancer Institute
Safety, Environmental & Facility Operations (SEF)

Mission:  To provide a forum for sharing information, promoting responsible practices and disseminating timely information regarding regulatory changes. Discussions will address regulatory interpretations by key agency representatives and stakeholders as well as facility management and practical issues. 

Leadership – Co-Chairs:

  • Denise Aronson, President, Safety Partners
  • Elias Witman, MBA, Sustainability Coordinator,  Cell Signaling Technology
  • Adam Wyner, MPP, Senior Manager, Environmental Health & Safety, Vertex Pharmaceuticals
  • Shaina Jamani, Area Manager – New England Area, PHC Corporation of North America (PHCNA)

For more information, or to submit a topic of interest for a forum, submit this form to Chris Lindgren.

NOTE: All MassBio events adhere to our conference Diversity Policy and Anti-Harassment Policy.